Need Help? Call 1­-866-­796-­7386
« back to stock screener

  ANIK stock: Anika Therapeutics Inc

Current Rating
Hold/Sell

Previous Rating:

Hold/Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$46.19
Market Cap
670.2M
Sector
Health Care
Div. Growth
-
P/E
21.4
P/B
3.01
P/S
6.49
Dividend %
-
P/CF
-
P/FCF
70.9
Op. Cash Flow
23.8K
FCF
0.6
Op. Margin
49.00%
Net Margin
31.50%
ROE
15.60%
ROI
14.50%
ROA
14.30%
EPS Growth
7.70%
Current Ratio
19.4
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Nephros, Inc. (NEPH) $0.30 - - 16.2M Strong Buy
Enzon Pharmaceuticals Inc (ENZN) $0.24 - - 10.8M Strong Buy
RTI Surgical Inc (RTIX) $5.10 - - 232.5M Strong Buy
Encision Inc (ECIA) $0.40 - - 3.6M Strong Buy
Merus Labs International Inc ( (MSLI) $1.19 - - 91M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More